Form 4 for RMD ResMed|
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-15 · accession 0001127602-22-005282 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-16 | 2022-02-15 | RMD | Douglas Robert Andrew | Pres, COO | M - OptEx | $58.24 | +8,000 | 25.2K | +47% | +$465.9K |
| D | 2022-02-16 | 2022-02-15 | RMD | Douglas Robert Andrew | Pres, COO | S - Sale+OE | $235.81 | -8,000 | 17.2K | -32% | -$1.89M |
| D | 2022-02-16 | 2022-02-15 | RMD | Douglas Robert Andrew | Pres, COO | M - OptEx | $0.00 | -8,000 | 70.1K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-02-15 | M | A | 8,000 | $58.24 | 25,175 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-02-15 | S | D | 8,000 | $235.81 | 17,175 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2022-02-15 | M | D | 8,000 | $0.00 | 70,098 | D | $58.24 · 2016-11-11 to 2022-11-19 | 8,000 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |